961.14(4)(tb)30.b. b. 1-(5-fluoropentyl)-N-(1-naphthyl)-1H-indole-3-carboxamide, commonly known as 5F-NNEI or 5F-MN-24.
961.14(4)(tb)31. 31. Any compound structurally derived from 3-(pyridinoyl)indole by substitution at the nitrogen atom of the indole ring by alkyl, haloalkyl, cyanoalkyl, alkenyl, cycloalkylmethyl, cycloalkylethyl, 1-(N-methyl-2-piperidinyl)methyl, 2-(4-morpholinyl)ethyl, 1-(N-methyl-2-pyrrolidinyl)methyl, 1-(N-methyl-3-morpholinyl)methyl, or (tetrahydropyran-4-yl)methyl group, whether or not further substituted in the indole ring to any extent, whether or not substituted in the pyridine ring to any extent. Substances specified under this subdivision include:
961.14(4)(tb)31.a. a. 1-pentyl-3-(3-pyridinoyl)indole;
961.14(4)(tb)31.b. b. 1-(5-fluoropentyl)-3-(3-pyridinoyl)indole.
961.14(4)(tb)32. 32. N-(1-amino-3-methyl-1-oxobutan-2-yl)-1-(4-fluorobenzyl)-1H-indazole-3-carboxamide, commonly known as AB-FUBINACA.
961.14(4)(tb)33. 33. N-(1-amino-3,3-dimethyl-1-oxobutan-2-yl)-1-pentyl-1H-indazole-3-carboxamide, commonly known as ADB-PINACA.
961.14(4)(tb)34. 34. N-(1-amino-3-methyl-1-oxobutan-2-yl)-1-(cyclohexylmethyl)-1H-indazole-3-carboxamide, commonly known as AB-CHMINACA.
961.14(4)(tb)35. 35. N-(1-amino-3-methyl-1-oxobutan-2-yl)-1-pentyl-1H-indazole-3-carboxamide, commonly known as AB-PINACA).
961.14(4)(tb)36. 36. [1-(5-fluoropentyl)-1H-indazol-3-yl](naphthalen-1-yl)methanone, commonly known as THJ-2201.
961.14(4)(tb)37. 37. N-(1-amino-3,3-dimethyl-1-oxobutan-2-yl)-1-(cyclohexylmethyl)-1H-indazole-3-carboxamide, commonly known as MAB-CHMINACA or ADB-CHMINACA.
961.14(4)(tb)38. 38. Methyl 2-(1-(5-fluoropentyl)-1H-indazole-3-carboxamido)-3,3-dimethylbutanoate, commonly known as 5F-ADB.
961.14(4)(tb)38m. 38m. Methyl 2-(1-(4-fluorobutyl)-1H-indazole-3-carboxamido)-3,3-dimethylbutanoate, commonly known as 4F-MDMB-BINACA or 4F-MDMB-BUTINACA.
961.14(4)(tb)39. 39. Methyl 2-(1-(5-fluoropentyl)-1H-indazole-3-carboxamido)-3-methylbutanoate, commonly known as 5F-AMB.
961.14(4)(tb)40. 40. N-(1-amino-3,3-dimethyl-1-oxobutan-2-yl)-1-(4-fluorobenzyl)-1H-indazole-3-carboxamide, commonly known as ADB-FUBINACA.
961.14(4)(tb)41. 41. Methyl 2-(1-(cyclohexylmethyl)-1H-indole-3-carboxamido)-3,3-dimethylbutanoate commonly known as MDMB-CHMICA.
961.14(4)(tb)42. 42. Methyl 2-(1-(4-fluorobenzyl)-1H-indazole-3-carboxamido)-3,3-dimethylbutanoate, commonly known as MDMB-FUBINACA.
961.14(4)(tb)43. 43. Methyl 2-(1-(4-fluorobenzyl)-1H-indazole-3-carboxamido)-3-methylbutanoate, commonly known as FUB-AMB, MMB-FUBINACA or AMB-FUBINACA.
961.14(4)(tb)43m. 43m. Methyl 2-(1-(4-fluorobenzyl)-1H-indole-3-carboxamido)-3-methylbutanoate, commonly known as MMB-FUBICA or AMB-FUBICA.
961.14(4)(tb)44. 44. Naphthalen-1-yl 1-(5-fluoropentyl)-1H-indole-3-carboxylate, commonly known as NM2201.
961.14(4)(tb)45. 45. N-(1-amino-3-methyl-1-oxobutan-2-yl)-1-(5-fluoropentyl)-1H-indazole-3-carboxamide, commonly known as 5F-AB-PINACA.
961.14(4)(tb)46. 46. 1-(4-cyanobutyl)-N-(2-phenylpropan-2-yl)-1H-indazole-3-carboxamide, commonly known as 4-CN-CUMYL-BUTINACA.
961.14(4)(tb)47. 47. Methyl 2-(1-(cyclohexylmethyl)-1H-indole-3-carboxamido)-3-methylbutanoate, commonly known as MMB-CHMICA.
961.14(4)(tb)48. 48. 1-(5-fluoropentyl)-N-(2-phenylpropan-2-yl)-1H-pyrrolo[2,3-b]pyridine-3-carboxamide, commonly known as 5F-CUMYL-P7AICA.
961.14(4)(tb)49. 49. Ethyl 2-(1-(5-fluoropentyl)-1H-indazole-3-carboxamido)-3,3-dimethylbutanoate, commonly known as 5F-EDMB-PINACA.
961.14(4)(tb)50. 50. Methyl 2-(1-(5-fluoropentyl)-1-indole-3-carboxamido)-3,3-dimethylbutanoate, commonly known as 5F-MDMB-PICA.
961.14(4)(tb)51. 51. N-(adamantan-1-yl)-1-(4-fluorobenzyl)-1H-indazole-3-carboxamide, commonly known as FUB-AKB48, FUB-APINACA or AKB48 N-(4-FLUOROBENZYL).
961.14(4)(tb)52. 52. 1-(5-fluoropentyl)-N-(2-phenylpropan-2-yl)-1H-indazole-3-carboxamide, commonly known as 5F-CUMYL-PINACA or SGT-25.
961.14(4)(tb)53. 53. (1-(4-fluorobenzyl)-1H-indol-3-yl)(2,2,3,3-tetramethylcyclopropyl)methanone, commonly known as FUB-144.
961.14(4)(u) (u) 1-[1-(2-thienyl)cyclohexyl]piperidine, which is the thiophene analog of phencyclidine;
961.14(4)(ud) (ud) 1-[1-(2-thienyl)cyclohexyl]pyrrolidine, which is the thiophene pyrrolidine analog of phencyclidine;
961.14(4)(ug) (ug) N-ethyl-1-phenylcyclohexylamine, which is the ethylamine analog of phencyclidine;
961.14(4)(ur) (ur) 1-(1-phenylcyclohexyl)pyrrolidine, which is the pyrrolidine analog of phencyclidine;
961.14(4)(uv) (uv) 2-(3-methoxyphenyl)-2-(ethylamino)cyclohexanone, commonly known as methoxetamine.
961.14(4)(v) (v) 2,5-dimethoxyamphetamine;
961.14(4)(w) (w) 4-bromo-2,5-dimethoxyamphetamine, commonly known as “DOB";
961.14(4)(wa) (wa) 4-iodo-2,5-dimethoxyamphetamine, commonly known as DOI.
961.14(4)(wb) (wb) 4-chloro-2,5-dimethoxyamphetamine, commonly known as DOC.
961.14(4)(wg) (wg) 4-bromo-2,5-dimethoxy-beta-phenylethylamine, commonly known as “2C-B" or “Nexus";
961.14(4)(wgm) (wgm) 4-iodo-2,5-dimethoxy-beta-phenylethylamine, commonly known as “2C-I".
961.14(4)(wh) (wh) 2,5 dimethoxy-4-(n)-propylthiophenethylamine, commonly known as “2C-T-7";
961.14(4)(wi) (wi) Alpha-methyltryptamine, commonly known as “AMT";
961.14(4)(wj) (wj) 5-methoxy-N, N-diisopropyltryptamine, commonly known as “5-MeO-DIPT";
961.14(4)(wk) (wk) 2,5-dimethoxy-4-ethylphenethylamine, commonly known as 2C-E.
961.14(4)(wL) (wL) 2,5-dimethoxy-4-methylphenethylamine, commonly known as 2C-D.
961.14(4)(wm) (wm) 2,5-dimethoxy-4-chlorophenethylamine, commonly known as 2C-C.
961.14(4)(wn) (wn) 2,5-dimethoxy-4-ethylthiophenethylamine, commonly known as 2C-T-2.
961.14(4)(wo) (wo) 2,5-dimethoxy-4-isopropylthiophenethylamine, commonly known as 2C-T-4.
961.14(4)(wp) (wp) 2,5-dimethoxyphenethylamine, commonly known as 2C-H.
961.14(4)(wq) (wq) 2,5-dimethoxy-4-nitrophenethylamine, commonly known as 2C-N.
961.14(4)(wr) (wr) 2,5-dimethoxy-4-(n)-propylphenethylamine, commonly known as 2C-P.
961.14(4)(ws) (ws) Any compound structurally derived from N-benzyl-2-(2,5-dimethoxyphenyl)ethanamine by substitution at the nitrogen atom, or on either ring, with alkyl, alkoxy, alkylenedioxy, haloalkyl, hydroxyl, halide or nitro substituents, or by any combination of these modifications. Substances specified under this paragraph include:
961.14(4)(ws)1. 1. 2-(4-iodo-2,5-dimethoxyphenyl)-N-[(2-methoxyphenyl)methyl]ethanamine, commonly known as 25I-NBOMe.
961.14(4)(ws)2. 2. 2-(4-chloro-2,5-dimethoxyphenyl)-N-[(2-methoxyphenyl)methyl]ethanamine, commonly known as 25C-NBOMe.
961.14(4)(ws)3. 3. 2-(4-bromo-2,5-dimethoxyphenyl)-N-[(2-methoxyphenyl)methyl]ethanamine, commonly known as 25B-NBOMe.
961.14(4)(ws)4. 4. 2-(4-ethyl-2,5-dimethoxyphenyl)-N-(2-methoxybenzyl)ethanamine, commonly known as 25E-NBOMe.
961.14(4)(wv) (wv) N,N-diallyl-5-methoxytryptamine, commonly known as 5-MeO-DALT.
961.14(4)(ww) (ww) 5-(2-aminopropyl)benzofuran, commonly known as 5-APB.
961.14(4)(wx) (wx) 6-(2-aminopropyl)benzofuran, commonly known as 6-APB.
961.14(4)(wy) (wy) 5-(2-aminopropyl)-2,3-dihydrobenzofuran, commonly known as 5-APDB.
961.14(4)(wz) (wz) 6-(2-aminopropyl)-2,3-dihydrobenzofuran, commonly known as 6-APDB.
961.14(4)(x) (x) 4-methoxyamphetamine, commonly known as “PMA."
961.14(4)(xa) (xa) 5-iodo-2-aminoindane, commonly known as 5-IAI.
961.14(4)(xb) (xb) 4-methoxymethamphetamine, commonly known as PMMA.
961.14(5) (5)Depressants. Any material, compound, mixture or preparation which contains any quantity of any of the following substances having a depressant effect on the central nervous system, including any of their salts, isomers and salts of isomers that are theoretically possible within the specific chemical designation:
961.14(5)(ag) (ag) Gamma-hydroxybutyric acid (commonly known as gamma hydroxybutyrate or “GHB"), gamma-butyrolactone, and 1,4-butanediol.
961.14(5)(am) (am) Mecloqualone.
961.14(5)(b) (b) Methaqualone.
961.14(7) (7)Stimulants. Any material, compound, mixture or preparation which contains any quantity of any of the following substances having a stimulant effect on the central nervous system, including any of their salts, isomers and salts of isomers that are theoretically possible within the specific chemical designation:
961.14(7)(ag) (ag) Cathinone.
961.14(7)(am) (am) Aminorex.
961.14(7)(b) (b) Fenethylline.
961.14(7)(c) (c) N-ethylamphetamine.
961.14(7)(cm) (cm) 4,4'-Dimethylaminorex.
961.14(7)(d) (d) 4-methylaminorex.
961.14(7)(e) (e) N,N-dimethylamphetamine.
961.14(7)(L) (L) Substituted cathinones. Any compound, except bupropion or compounds scheduled elsewhere in this chapter, that is structurally derived from 2-amino-propan-1-one by substitution at the 1-position with either phenyl, napthyl, or thiophene ring systems, whether or not the compound is further modified in any of the following ways: by substitution in the ring system to any extent with alkyl, alkoxy, alkylenedioxy, haloalkyl, hydroxyl, or halide substituents, whether or not further substituted in the ring system by one or more other univalent substituents; by substitution at the 3-position with an acyclic alkyl substituent; by substitution at the 2-amino nitrogen atom with alkyl, dialkyl, benzyl, or methoxybenzyl groups; by inclusion of the 2-amino nitrogen atom in a cyclic structure; or by any combination of these modifications. Substances specified under this subdivision include:
961.14(7)(L)1. 1. Methcathinone.
961.14(7)(L)2. 2. Methylenedioxypyrovalerone, commonly known as MDPV.
961.14(7)(L)3. 3. 4-methylmethcathinone, commonly known as mephedrone or 4-MMC.
961.14(7)(L)4. 4. 4-methylethcathinone, commonly known as 4-MEC.
961.14(7)(L)5. 5. 4-methoxy-alpha-pyrrolidinopropiophenone, commonly known as MOPPP.
961.14(7)(L)6. 6. 3,4-methylenedioxy-alpha-pyrrolidinopropiophenone, commonly known as MDPPP.
961.14(7)(L)7. 7. Alpha-pyrrolidinovalerophenone, commonly known as alpha-PVP.
961.14(7)(L)8. 8. 2-fluoromethcathinone, commonly known as 2-FMC.
961.14(7)(L)9. 9. 3-fluoromethcathinone, commonly known as 3-FMC.
961.14(7)(L)10. 10. 4-fluoromethcathinone, commonly known as 4-FMC or flephedrone.
961.14(7)(L)11. 11. 3,4-methylenedioxymethcathinone, commonly known as methylone or bk-MDMA.
961.14(7)(L)12. 12. Naphthylpyrovalerone, commonly known as naphyrone.
961.14(7)(L)13. 13. 4-methyl-alpha-pyrrolidinobutiophenone, commonly known as MPBP.
2019-20 Wisconsin Statutes updated through 2021 Wis. Act 267 and through all Supreme Court and Controlled Substances Board Orders filed before and in effect on November 16, 2022. Published and certified under s. 35.18. Changes effective after November 16, 2022, are designated by NOTES. (Published 11-16-22)